Petrioli, R., Pascucci, A., Conca, R., Chiriacò, G., Francini, E., Bargagli, G., . . . Francini, G. (2011). Docetaxel and epirubicin compared with docetaxel and prednisone in advanced castrate-resistant prostate cancer: A randomised phase II study. Nature Publishing Group.
استشهاد بنمط شيكاغوPetrioli, R., et al. Docetaxel and Epirubicin Compared With Docetaxel and Prednisone in Advanced Castrate-resistant Prostate Cancer: A Randomised Phase II Study. Nature Publishing Group, 2011.
MLA استشهادPetrioli, R., et al. Docetaxel and Epirubicin Compared With Docetaxel and Prednisone in Advanced Castrate-resistant Prostate Cancer: A Randomised Phase II Study. Nature Publishing Group, 2011.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.